Page last updated: 2024-10-15
ur 12746
Description
UR 12746: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 135484128 |
CHEMBL ID | 102620 |
SCHEMBL ID | 3045662 |
MeSH ID | M0377833 |
Synonyms (18)
Synonym |
---|
dersalazina |
CHEMBL102620 |
dersalazine |
188913-58-8 |
2-hydroxy-5-((4-((1z)-3-(4-((2-methyl-1h-imidazo(4,5-c)pyridin-1-yl)methyl)piperidin-1-yl)-3-oxo-1-phenylprop-1-enyl)phenyl)diazenyl)benzoic acid |
unii-ws1ih75ajt |
ur 12746 |
dersalazina [inn-spanish] |
ur-12746 |
dersalazine [inn] |
ws1ih75ajt , |
dersalazine [who-dd] |
benzoic acid, 2-hydroxy-5-((4-((1z)-3-(4-((2-methyl-1h-imidazo(4,5-c)pyridin-1-yl)methyl)-1-piperidinyl)-3-oxo-1-phenyl-1-propenyl)phenyl)azo)- |
SCHEMBL3045662 |
DB06251 |
Q27292798 |
2-hydroxy-5-[[4-[(z)-3-[4-[(2-methylimidazo[4,5-c]pyridin-1-yl)methyl]piperidin-1-yl]-3-oxo-1-phenylprop-1-enyl]phenyl]diazenyl]benzoic acid |
(3e)-3-[[4-[(z)-3-[4-[(2-methylimidazo[4,5-c]pyridin-1-yl)methyl]piperidin-1-yl]-3-oxo-1-phenylprop-1-enyl]phenyl]hydrazinylidene]-6-oxocyclohexa-1,4-diene-1-carboxylic acid |
Toxicity
Excerpt | Reference |
---|---|
" Adverse events at least possibly related to treatment were observed in 23%, 12." | ( Safety and activity of dersalazine sodium in patients with mild-to-moderate active colitis: double-blind randomized proof of concept study. Panés, J; Pontes, C; Torres, F; Vives, R, 2014) |
" Weekly measurements of liver function tests may be necessary for early detection of adverse events." | ( Safety and activity of dersalazine sodium in patients with mild-to-moderate active colitis: double-blind randomized proof of concept study. Panés, J; Pontes, C; Torres, F; Vives, R, 2014) |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Bioassays (7)
Research
Studies (6)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 3 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 2 (33.33%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 4 (66.67%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |